News

Novo Nordisk NVO and Jazz Pharmaceuticals JAZZ reported their first-quarter results. AstraZeneca’s AZN late-stage asthma ...
President of Lilly Oncology; and Patrik Johnson, President of Cardiometabolic Metabolic Health and Lilly USA. We're also joined by Mark Keman, Wes Tall and Wai Wong of the Investor Relations team.
President of Lilly Oncology; and Patrik Johnson, President of Cardiometabolic Metabolic Health and Lilly USA. We're also joined by Mark Keman, Wes Tall and Wai Wong of the Investor Relations team.
We recently published a list of the 15 Best Growth Stocks to Buy for the Next 3 Years. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other ...
Eli Lilly and Company (LLY) reported its first-quarter results for 2025, revealing a revenue increase of 45% compared to the same period last year, driven by strong sales of key products. The company ...
Eli Lilly and Company (LLY) reported its first-quarter results for 2025, revealing a revenue increase of 45% compared to the same period last year, driven by strong sales of key products.
Lilly also announced in January that it would be expanding its oncology pipeline by acquiring Scorpion Therapeutics’ PI3Kα inhibitor programme in a deal worth up to $2.5bn, and partnered with Alchemab ...
Here's your look at the Hello Sunshine teaser trailer for this upcoming survival mystery RPG set in the ruins of a corporate empire. Walk in the shadow of a giant robot during the hot days; stay ...
Apple also tweaked AppleCare information in the Settings app, adding a banner with an AppleCare logo and other details about coverage. There are also references to the upcoming Pride wallpaper ...
Title: Efficacy of second line (2L) treatment with tivozanib (Tivo) as monotherapy or with nivolumab (Nivo) in patients (pts) with metastatic renal cell carcinoma (mRCC) previously treated with an ...
BOSTON, April 28, 2025 /PRNewswire/ -- AVEO Oncology, an LG Chem company ("AVEO"), a biopharmaceutical company committed to providing differentiated solutions to improve cancer patients lives ...